Cigarette smoking and kidney dysfunction in diabetes mellitus

Area of Science:

• Nephrology
• Endocrinology
• Public Health

Background:

• Type 2 diabetes mellitus is a primary cause of end-stage renal disease in Western countries.
• Smoking is an underappreciated factor contributing to renal damage and microvascular dysfunction.
• Mechanisms of smoking-induced renal damage overlap with those in diabetic kidney disease, potentially exacerbating redox homeostasis.

Purpose of the Study:

• To examine the combined impact of type 2 diabetes and smoking on renal function.
• To evaluate the potential for this association to accelerate kidney insufficiency and failure.

Main Methods:

• Review of epidemiological studies.
• Analysis of physiopathological mechanisms linking diabetes, smoking, and renal damage.
• Assessment of renal redox homeostasis in affected individuals.

Main Results:

• The combination of diabetes and smoking significantly increases the risk of developing or progressing renal insufficiency.
• Synergistic effects between diabetes and smoking accelerate the decline in kidney function.
• Evidence supports the detrimental impact on renal redox balance.

Conclusions:

• The co-occurrence of type 2 diabetes and smoking is strongly associated with accelerated progression to kidney failure.
• Smoking prevention and cessation are crucial for diabetic patients to mitigate cardiovascular and renal risks.
• Interventions targeting smoking cessation are vital for preserving kidney function in this population.